Investing Ideas
/
Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

1 companies

Lytix Biopharma

Market Cap: NOK 598.3m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

LYTIX

NOK 8.00

5.5%

-12.7%